All Releases

Nov 19, 2012
ALBANY, N.Y. , Nov. 19, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference at
Oct 16, 2012
AngioDynamics Completes Acquisition of Vortex Medical
ALBANY, N.Y. , Oct. 16, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that it has completed the acquisition of Vortex Medical Inc.
Oct 08, 2012
AngioDynamics Reports Fiscal 2013 First Quarter Financial Results
Net sales of $83.4 million GAAP net loss of $0.02 per share; Adjusted (Non-GAAP) net income of $0.10 per share, a YOY 25% increase Integration of Navilyst Medical yielding significant cost savings Vortex Medical acquisition to strengthen peripheral vascular portfolio ALBANY, N.Y. , Oct.
Oct 04, 2012
AngioDynamics Awarded $16.5 Million Judgment in Case Against biolitec Inc.
ALBANY, N.Y. , Oct. 4, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced a recent court action in its legal case against biolitec Inc.
Sep 27, 2012
AngioDynamics Bolsters Senior Leadership Team With Key Appointments
ALBANY, N.Y. , Sept. 27, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Louis J.
Sep 05, 2012
AngioDynamics to Present at the 10th Annual CL King Best Ideas Conference
ALBANY, N.Y. , Sept. 5, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 10th Annual CL King Best Ideas Conference at the
Aug 09, 2012
AngioDynamics to Present at the 32nd Annual Canaccord Growth Conference
ALBANY, N.Y. , Aug. 9, 2012 (GLOBE NEWSWIRE) -- Angiodynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 32 nd Annual Canaccord Growth Conference at the
Jul 13, 2012
AngioDynamics, Inc. [ANGO] to Ring The NASDAQ Stock Market Closing Bell
ADVISORY, July 13, 2012 (GLOBE NEWSWIRE) -- What: AngioDynamics [ANGO], a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will visit the NASDAQ MarketSite in Times Square .
Jul 12, 2012
Net sales of $57.7 million with Navilyst Medical contributing $4.8 million GAAP net loss of $7.0 million , or $0.27 per share; adjusted (Non-GAAP) net income of $2.6 million , or $0.10 per share, including $0.01 from Navilyst Medical Integration of Navilyst Medical is progressing on schedule
Jul 02, 2012
ALBANY, N.Y. , July 2, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the publication of a study in the Journal of the American College of
May 22, 2012
AngioDynamics Completes Acquisition of Navilyst Medical
ALBANY, N.Y. , May 22, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced it has completed its acquisition of Navilyst Medical .
May 15, 2012
ALBANY, N.Y. , May 15, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the Company's shareholders approved the issuance of approximately
Apr 23, 2012
AngioDynamics Resumes NanoKnife(R) System Shipments in the U.S.
ALBANY, N.Y. , April 23, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the resumption of shipments of its NanoKnife ® System in